Protective effects of the FOXO3 gene in cardiometabolic disease in the Concord Health and Ageing in Men Project cohort
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 07.04.2026 · 81 (5)
DOI: 10.1093/gerona/glag063 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 15.03.2026. Verfasst von Lovina Abdi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biogenesis Research, Department of Anatomy, Biochemistry, and Physiology, John A. Burns School of Medicine, University of Hawaii, Honol…. Hauptthemen laut MEDLINE: Forkhead Box Protein O3, Longevity, Aging, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: University of Hawaii John A. Burns School of Medicine and Kuakini Medical Center.
Abstract (Originalsprache)
Recent findings from the Honolulu Heart Program cohort in Hawaii suggest a longevity-associated variant of Forkhead box O3 (FOXO3) may provide resilience against cardiometabolic diseases (CMDs), such as hypertension, diabetes, and angina. The present study utilizes data from the Concord Health and Ageing in Men Project (CHAMP) cohort in Australia to further investigate the impact of the longevity-associated FOXO3 variant on CMD and longevity. Specifically, the protective “G” allele of rs2802292 was examined for potential protective effects against mortality in individuals with hypertension, diabetes, or angina (p-value: .01). Although no significant impact on mortality was observed in individuals with hypertension or diabetes, a reduced risk of mortality was observed for G allele carriers with angina. These findings are consistent with prior research linking longevity-associated FOXO3 variants to increased lifespan in individuals with heart disease and provide further evidence of its importance as a genetic factor influencing CMD risk. The protective effects against heart disease may arise from FOXO3’s ability to enhance cellular resilience against oxidative stress and regulate metabolic pathways crucial for cardiovascular function. Additional studies are needed to fully understand the mechanisms behind FOXO3’s influence on CMD, in particular heart disease, and to explore its potential for therapeutic development. This research highlights the relevance of genetic factors, specifically FOXO3, in CMD prevention and longevity in the elderly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biogenesis Research, Department of Anatomy, Biochemistry, and Physiology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States.
- ANZAC Research Institute, University of Sydney and Concord Hospital, Sydney, New South Wales, Australia.
- Concord Clinical School, University of Sydney, Sydney, New South Wales, Australia.
- Centre for Education and Research on Ageing, Department of Geriatric Medicine, Concord Repatriation Hospital, Sydney, New South Wales, Australia.
- Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii at Manoa; Kuakini Medical Center, Honolulu, Hawaii, United States.
ORCID-Profile: Lovina Abdi, David Le Couteur, Vasi Naganathan, Louise M Waite, Bradley Willcox, Richard Allsopp
Förderung
- University of Hawaii John A. Burns School of Medicine and Kuakini Medical Center
Zitieren
APA
Abdi, L., Lockwood, G., Le Couteur, D., Handelsman, D. J., Naganathan, V., Blyth, F., Waite, L. M., Cogger, V., Willcox, B., & Allsopp, R. (2026). Protective effects of the FOXO3 gene in cardiometabolic disease in the Concord Health and Ageing in Men Project cohort. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(5). https://doi.org/10.1093/gerona/glag063
Vancouver
Abdi L, Lockwood G, Le Couteur D, Handelsman DJ, Naganathan V, Blyth F, et al. Protective effects of the FOXO3 gene in cardiometabolic disease in the Concord Health and Ageing in Men Project cohort. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(5). doi:10.1093/gerona/glag063
BibTeX
@article{Abdi2026,
author = {Abdi, Lovina and Lockwood, Glen and Le Couteur, David and Handelsman, David J and Naganathan, Vasi and Blyth, Fiona and Waite, Louise M and Cogger, Victoria and Willcox, Bradley and Allsopp, Richard},
title = {Protective effects of the FOXO3 gene in cardiometabolic disease in the Concord Health and Ageing in Men Project cohort},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {5},
doi = {10.1093/gerona/glag063}
}
EUVIMED